Abbott Laboratories

Abbott Laboratories, founded in 1888 and headquartered in Abbott Park, Illinois, United States, is a diversified global healthcare company offering diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. The company reported revenues over $43 billion in fiscal 2022, supported by innovative products like the FreeStyle Libre and Alinity diagnostic platforms. Under the leadership of CEO Robert B. Ford since March 2020, Abbott has strengthened its position in more than 160 countries. Looking ahead, it is investing in next-generation digital health and expanding its global footprint to meet evolving market needs.

On October 11, 2024 Abbott's board authorized the repurchase of up to $7.0 billion of common shares (the 2024 program); $6.7 billion remained available as of December 31, 2025, and the cash-flow statement shows $893 million of common-share purchases in fiscal 2025.